An
article of interest in Frontiers in Cellular and Infection Microbiology. Here
is the abstract:
Almost
all integral membrane proteins found in the outer membranes of Gram-negative
bacteria belong to the transmembrane β-barrel family. These proteins are not
only important for nutrient uptake and homeostasis, but are also involved in
such processes as adhesion, protein secretion, biofilm formation, and
virulence. As surface exposed molecules, outer membrane β-barrel proteins are
also potential drug and vaccine targets. High production levels of
heterologously expressed proteins are desirable for biochemical and especially
structural studies, but over-expression and subsequent purification of membrane
proteins, including outer membrane proteins, can be challenging.
Here,
we present a set of deletion mutants derived from E. coli BL21(DE3) designed
for the over-expression of recombinant outer membrane proteins. These strains
harbor deletions of four genes encoding abundant β-barrel proteins in the outer
membrane (OmpA, OmpC, OmpF, and LamB), both single and in all combinations of
double, triple, and quadruple knock-outs. The sequences encoding these outer
membrane proteins were deleted completely, leaving only a minimal scar
sequence, thus preventing the possibility of genetic reversion.
Expression
tests in the quadruple mutant strain with four test proteins, including a small
outer membrane β-barrel protein and variants thereof as well as two
virulence-related autotransporters, showed significantly improved expression
and better quality of the produced proteins over the parent strain.
Differences
in growth behavior and aggregation in the presence of high salt were observed,
but these phenomena did not negatively influence the expression in the
quadruple mutant strain when handled as we recommend. The strains produced in
this study can be used for outer membrane protein production and purification,
but are also uniquely useful for labeling experiments for biophysical
measurements in the native membrane environment.
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources